Please create an account first.

$PCSV
PCS Edventures!, Inc. Stock $pcsv

$pcsv Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000149315224025592 Filed on June 28, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$3.160M	$2.263M	$9.094M
YoY Change	21.29%		29.84%
Cost Of Revenue	$1.198M	$856.3K	$3.360M
YoY Change	19.36%		20.05%
Gross Profit	$1.961M	$1.407M	$5.735M
YoY Change	22.5%		36.35%
Gross Profit Margin	62.07%	62.16%	63.06%
Selling, General & Admin	$838.3K	$792.6K	$2.928M
YoY Change			22.31%
% of Gross Profit	42.74%	56.35%	51.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.360K	$3.630K	$11.49K
YoY Change	84.2%		124.11%
% of Gross Profit	0.22%	0.26%	0.2%
Operating Expenses	$838.3K	$792.6K	$2.928M
YoY Change	13.11%		22.31%
Operating Profit	$1.123M	$613.9K	$2.807M
YoY Change	30.59%		54.88%
Interest Expense	$21.51K	$18.13K	$48.90K
YoY Change			-134.29%
% of Operating Profit	1.92%	2.95%	1.74%
Other Income/Expense, Net		$21.51K	$55.42K
YoY Change			-41.58%
Pretax Income	$1.145M	$653.6K	$2.911M
YoY Change	33.05%		64.98%
Income Tax		-$1.530M	-$1.530M
% Of Pretax Income		-234.07%	-52.55%
Net Earnings	$1.145M	$2.183M	$4.441M
YoY Change	33.05%		59.98%
Net Earnings / Revenue	36.23%	96.49%	48.83%
Basic Earnings Per Share	$0.01		$0.04
Diluted Earnings Per Share	$0.01	$0.02	$0.04
COMMON SHARES
Basic Shares Outstanding	124.7M shares	124.7M shares	125.1M shares
Diluted Shares Outstanding	124.7M shares		125.1M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.653M	$1.330M	$1.330M
YoY Change			200.39%
Cash & Equivalents	$2.650M	$1.300M
Short-Term Investments
Other Short-Term Assets	$490.9K	$394.1K	$394.1K
YoY Change			-9.64%
Inventory	$2.040M	$2.000M	$2.025M
Prepaid Expenses	$490.9K	$394.1K
Receivables	$1.599M	$1.676M	$1.676M
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$6.782M	$5.425M	$5.425M
YoY Change		117.54%	117.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.21K	$43.74K	$317.6K
YoY Change		38.71%	55.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.548M	$2.548M	$2.548M
YoY Change			150.31%
Total Long-Term Assets	$2.862M	$2.865M	$2.865M
YoY Change		134.34%	134.34%
TOTAL ASSETS
Total Short-Term Assets	$6.782M	$5.425M	$5.425M
Total Long-Term Assets	$2.862M	$2.865M	$2.865M
Total Assets	$9.645M	$8.290M	$8.290M
YoY Change		123.07%	123.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$219.3K	$100.9K	$90.80K
YoY Change		261.13%	382.72%
Accrued Expenses	$282.6K	$230.0K	$257.4K
YoY Change		1.65%	-15.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$648.1K	$416.2K	$416.2K
YoY Change		14.24%	14.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$196.2K	$218.4K	$218.4K
YoY Change			200.25%
Total Long-Term Liabilities	$196.2K	$218.4K	$218.4K
YoY Change		200.27%	200.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$648.1K	$416.2K	$416.2K
Total Long-Term Liabilities	$196.2K	$218.4K	$218.4K
Total Liabilities	$844.3K	$634.5K	$634.5K
YoY Change		45.2%	45.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.77M	-$32.91M
YoY Change		-11.89%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.801M	$7.656M	$7.656M
YoY Change
Total Liabilities & Shareholders Equity	$9.645M	$8.290M	$8.290M
YoY Change		123.07%	123.06%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$1.145M	$2.183M	$4.441M
YoY Change	33.05%		59.98%
Depreciation, Depletion And Amortization	$4.360K	$3.630K	$11.49K
YoY Change	84.2%		124.11%
Cash From Operating Activities	$1.353M	-$669.3K	$975.7K
YoY Change	122.06%		-27.26%
INVESTING ACTIVITIES
Capital Expenditures	$29.83K	$7.600K	$23.70K
YoY Change	288.08%		21.55%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$29.83K	-$7.600K	-$23.70K
YoY Change	288.08%		21.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$64.93K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000	-$64.93K
YoY Change			-95.56%
NET CHANGE
Cash From Operating Activities	$1.353M	-669.3K	$975.7K
Cash From Investing Activities	-$29.83K	-7.600K	-$23.70K
Cash From Financing Activities		0.000	-$64.93K
Net Change In Cash	$1.323M	-676.9K	$887.1K
YoY Change	119.94%		-727.28%
FREE CASH FLOW
Cash From Operating Activities	$1.353M	-$669.3K	$975.7K
Capital Expenditures	$29.83K	$7.600K	$23.70K
Free Cash Flow	$1.323M	-$676.9K	$952.0K
YoY Change	119.94%		-27.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Auditor Name AuditorName	Haynie & Company
CY2024	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2024	dei	Auditor Firm AuditorFirmId	457
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	21108	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14985	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	229970	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	226231	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1529793	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1011466	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2024Q1	PCSV	Deferred Tax Assets Right Of Use Liabilities DeferredTaxAssetsRightOfUseLiabilities	76693	usd
CY2023Q1	PCSV	Deferred Tax Assets Right Of Use Liabilities DeferredTaxAssetsRightOfUseLiabilities	48539	usd
CY2024Q1	PCSV	Deferred Tax Assets Goodwill Amortization DeferredTaxAssetsGoodwillAmortization	13121	usd
CY2023Q1	PCSV	Deferred Tax Assets Goodwill Amortization DeferredTaxAssetsGoodwillAmortization	15041	usd
CY2023Q1	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	19	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2539181	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3255242	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2628995	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	76693	usd
CY2024Q1	PCSV	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	11043	usd
CY2023Q1	PCSV	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	5101	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	87736	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2541259	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3265201	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2253735	usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001122020
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets		usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2024	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2024Q1	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards		usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2024	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome		usd
CY2024	PCSV	Expiration Of Operating Loss Carryforward ExpirationOfOperatingLossCarryforward		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-49990
CY2024	dei	Entity Registrant Name EntityRegistrantName	PCS Edventures!, Inc.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	ID
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-0475383
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	11915 W. Executive Dr.
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 101
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	12821533	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	124733494	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1329708	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	442657	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	34204	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18469	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1675859	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	363947	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	13312	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	394091	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	436118	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2025483	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1237872	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	5425141	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2493906	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	273905	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	173352	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6300	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6300	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43739	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31533	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2541259	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1011466	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	2865203	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1222651	usd
CY2024Q1	us-gaap	Assets Assets	8290344	usd
CY2023Q1	us-gaap	Assets Assets	3716557	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	100853	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	27927	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	229970	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	226231	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	14549	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7085	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	70782	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	103026	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	416154	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	364269	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	218373	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	72726	usd
CY2024Q1	us-gaap	Liabilities Liabilities	634527	usd
CY2023Q1	us-gaap	Liabilities Liabilities	436995	usd
CY2024Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	124733494	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	124733494	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	125732479	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125732479	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40570459	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5127	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	139729	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40635392	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32914642	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37355830	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7655817	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3279562	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8290344	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3716557	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9094466	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7004575	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3359801	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2798617	usd
CY2024	us-gaap	Salaries And Wages SalariesAndWages	1778946	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	1521536	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1148652	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	871967	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	2927598	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2393503	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	2807067	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1812455	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	48904	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-142605	usd
CY2024	PCSV	Tax Credit TaxCredit	52766	usd
CY2023	PCSV	Tax Credit TaxCredit	94860	usd
CY2024	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	2658	usd
CY2024	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	104328	usd
CY2023	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-47745	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2911395	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1764710	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1529793	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1011466	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	4441188	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2776176	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125070138	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125109876	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125070138	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125109876	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	457396	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2776176	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	30000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	15990	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3279562	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3279562	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	4441188	usd
CY2024	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-64933	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7655817	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	7655817	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	4441188	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2776176	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	15990	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11490	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	93328	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1529793	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1011466	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1298599	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3277	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	177173	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	350389	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	787611	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	78245	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-92002	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	295864	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-112994	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-126878	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-91928	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7463	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7085	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	975680	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1341409	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23696	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19495	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23696	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19495	usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	64933	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1493327	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	30000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-64933	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1463327	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	887051	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-141413	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442657	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	584070	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1329708	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	442657	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	83440	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	56516	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	648	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	142605	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1329708	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	442657	usd
CY2024Q1	PCSV	Prepaid Software PrepaidSoftware	17254	usd
CY2023Q1	PCSV	Prepaid Software PrepaidSoftware	16287	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	20899	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1698	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	394091	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	436118	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zYDrNeoFS5D6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_z4nHoOR1Ehx5">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these financial statements in conformity with Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include reserves related to accounts receivable and inventory, the valuation allowance related to deferred tax assets, the valuation of equity instruments, and debt discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zsgBICHqYysg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_zKoJkKog03Yj">Concentration of Credit Risks and Significant Customers</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company extends credit to customers and is therefore subject to credit risk. Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of trade receivables. In the normal course of business, the Company provides credit terms to its customers. Accordingly, the Company performs ongoing credit evaluations of its customers and maintains allowances for possible losses which, when realized, have been within the range of management’s expectations. An allowance for doubtful accounts is recorded to account for potential bad debts. Estimates are used in determining the allowance for doubtful accounts and are based upon an assessment of selected accounts, historic averages, and as a percentage of remaining accounts receivable by aging category. In determining these percentages, the Company evaluates historical write-offs, and current trends in customer credit quality, as well as changes in credit policies. The Company generally does not require collateral from its customers. The Company has established an allowance for doubtful accounts of $<span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240331_zibxuOLVQIcd" title="Allowance for doubtful accounts">34,204</span> as of March 31, 2024, and $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20230331_zzARFQogMp9" title="Allowance for doubtful accounts">18,469</span> as of March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zxIdLymBufL7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following Table shows the Company’s concentration of credit risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B2_zJIoppBo8Boc">SCHEDULE OF CONCENTRATION OF CREDIT RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right">2024 % of</td><td style="text-align: right"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right">3/31/2024</td><td style="text-align: right"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right">2023 % of</td><td style="text-align: right"> </td><td style="text-align: right"> </td> <td colspan="2" style="text-align: right">3/31/2023</td><td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td style="text-align: right; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">Revenue</td><td style="text-align: right; padding-bottom: 1.5pt"> </td><td style="text-align: right; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">% of A/R</td><td style="text-align: right; padding-bottom: 1.5pt"> </td><td style="text-align: right; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">Revenue</td><td style="text-align: right; padding-bottom: 1.5pt"> </td><td style="text-align: right; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: right">% of A/R</td><td style="text-align: right; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Customer A</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zs92MB6CzQYh" title="Concentration of credit risk">6.6</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zke3JWPmwewc" title="Concentration of credit risk">2.0</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z7wmRBECDOea" title="Concentration of credit risk">4.2</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zPQYKhO79sc4" title="Concentration of credit risk">9.7</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zWRQ4HaIVn27" title="Concentration of credit risk">12.1</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zO5BMDoeAHGl" title="Concentration of credit risk">76.7</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zRJeP8VcTNVc" title="Concentration of credit risk">6.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zmFTyS25w0V7" title="Concentration of credit risk">45.1</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zJDKwkFEutUd" title="Concentration of credit risk">13.7</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zURFHUZ2ZES" title="Concentration of credit risk">0.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zXyop3IueUc6" title="Concentration of credit risk">37.3</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z3O7H8OJnq1f" title="Concentration of credit risk">0.0</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z7dqvkv6GzBh" title="Concentration of credit risk">5.0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zf8p6HO9aw7b" title="Concentration of credit risk">3.2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zbDhk3SsQwtb" title="Concentration of credit risk">5.2</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zTpR6NUPepM5" title="Concentration of credit risk">6.8</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zliDUh3Rg952" title="Concentration of credit risk">4.9</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20240331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z3lEaB5SuLI6" title="Concentration of credit risk">3.6</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zIE9kEKT4oa8" title="Concentration of credit risk">1.1</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zcMTQgnJ2aTl" title="Concentration of credit risk">7.8</span></td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8A0_zm9ZgCq4euo7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	34204	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18469	usd
CY2024Q1	us-gaap	Inventory Adjustments InventoryAdjustments	3274	usd
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	6343	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	62019	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18280	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43739	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31533	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6790	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	124733494	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	124733494	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	125732479	shares
CY2024Q1	PCSV	Operating Loss Carryforwards Percentage OperatingLossCarryforwardsPercentage	0.50	pure
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	14549	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7085	usd
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	125732479	shares
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	0	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	15990	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1250000	shares
CY2024	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	998985	shares
CY2024Q1	us-gaap	Share Price SharePrice	0.065
CY2024	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	64933	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125070138	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125109876	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125070138	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125109876	shares
CY2024	us-gaap	Net Income Loss NetIncomeLoss	4441188	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2776176	usd
CY2024Q1	PCSV	Dilutive Securities Outstanding DilutiveSecuritiesOutstanding	0	shares
CY2023Q1	PCSV	Dilutive Securities Outstanding DilutiveSecuritiesOutstanding	0	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1300000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2000000.0	usd
CY2024Q1	us-gaap	Inventory Supplies Net Of Reserves InventorySuppliesNetOfReserves	300000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1700000	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	34204	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18469	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	13312	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	10915	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	8891	usd
CY2024Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	25046	usd
CY2023Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	34316	usd
CY2024Q1	us-gaap	Supplies Supplies	319977	usd
CY2023Q1	us-gaap	Supplies Supplies	374926	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	PCSV	Dilutive Securities Outstanding DilutiveSecuritiesOutstanding	0	shares
CY2023Q1	PCSV	Dilutive Securities Outstanding DilutiveSecuritiesOutstanding	0	shares
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	82330	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	38892	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	43232	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	48024	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	53315	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	23362	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	289155	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	273905	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	70782	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	70782	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	218373	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	218373	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	289155	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2541259	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1011466	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	4200	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2355877	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	113596	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	240281	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	90800	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	18814	usd
CY2024Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	10053	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	9113	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	100853	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	27927	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	617681	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	376732	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	208403	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	127569	usd
CY2024Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	165087	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	201724	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	9969	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3399	usd
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	39929	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	21108	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14985	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	229970	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	226231	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1529793	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1011466	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2024Q1	PCSV	Deferred Tax Assets Right Of Use Liabilities DeferredTaxAssetsRightOfUseLiabilities	76693	usd
CY2023Q1	PCSV	Deferred Tax Assets Right Of Use Liabilities DeferredTaxAssetsRightOfUseLiabilities	48539	usd
CY2024Q1	PCSV	Deferred Tax Assets Goodwill Amortization DeferredTaxAssetsGoodwillAmortization	13121	usd
CY2023Q1	PCSV	Deferred Tax Assets Goodwill Amortization DeferredTaxAssetsGoodwillAmortization	15041	usd
CY2023Q1	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	19	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2539181	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3255242	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2628995	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3318841	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	76693	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	48539	usd
CY2024Q1	PCSV	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	11043	usd
CY2023Q1	PCSV	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	5101	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	87736	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	53640	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2541259	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2253735	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2541259	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1011466	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	617681	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	376732	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	208403	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	127569	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	4200	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2355877	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1511567	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1529793	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1011466	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	12111354	usd
CY2024	PCSV	Operating Loss Carryforwards Realized OperatingLossCarryforwardsRealized	2981269	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	9173444	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1511567	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1529793	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1011466	usd
CY2024	PCSV	Operating Loss Carryforwards Realized OperatingLossCarryforwardsRealized	2981269	usd

Files In Submission

Name	View Source	Status
0001493152-24-025592-index-headers.html	Edgar Link	pending
0001493152-24-025592-index.html	Edgar Link	pending
0001493152-24-025592.txt	Edgar Link	pending
0001493152-24-025592-xbrl.zip	Edgar Link	pending
ex14.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
ex4.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcsv-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pcsv-20240331_cal.xml	Edgar Link	unprocessable
pcsv-20240331_def.xml	Edgar Link	unprocessable
pcsv-20240331_lab.xml	Edgar Link	unprocessable
pcsv-20240331_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCSV
PCS Edventures!, Inc. Stock $pcsv

2024 Q2 Form 10-K Financial Statement

#000149315224025592 Filed on June 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCSV PCS Edventures!, Inc. Stock $pcsv

2024 Q2 Form 10-K Financial Statement

#000149315224025592 Filed on June 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCSV
PCS Edventures!, Inc. Stock $pcsv